Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2013
The aim of this study is to test the hypothesis, that the order of application of Busulfan (BU) and Cyclophosphamide (CY) has an impact on toxicity after allogeneic Hematopoietic stem cell transplantation (HSCT) and that CY-BU reduces liver toxicity compared to BU-CY.
Epistemonikos ID: 62b1aa784f30f894ded4adbf268388356a28a198
First added on: Jan 21, 2022